click below
click below
Normal Size Small Size show me how
Autonomic NS
PPT 3
Term | Definition |
---|---|
Somatic system | -associated with Ach NTs -Nicotinic receptors |
Parasympathetic Nervous System | "rest & digest" associated with Ach NTs -Muscarinic receptors |
Sympathetic Nervous System | "fight or flight" associated with NE NTs -Adrenergic and Dopamine receptors (a, b, D) *exception=sweat glands (Ach NT and M receptor) |
Structure of the SNS - location of preganglionic cell bodies | Thoraco-lumbar |
Structure of the PNS - location of preganglionic cell bodies | Cranio-sacral |
Structure of the SNS - location of ganglia, length of fibers | 1) sympathetic chain ganglia 2) collateral ganglia short preganglionic & long post-ganglionic |
Structure of the PNS - location of ganglia, length of fibers | near effector organ (terminal) long preganglionic & short post-ganglionic |
Structure of SNS vs PNS - divergence of neurons | more divergence in the SNS vs PNS |
CN lll | Oculomotor Nerve type-motor function-eye movement |
CN Vll | Facial Nerve type-mixed function-sensory for taste |
CN IX | Glossopharyngeal Nerve type-mixed function-sensory from oral cavity, baro- and chemoreceptors from blood vessels |
CN X | Vagus Nerve type-mixed function-sensory and efferent neurons from many organs |
important PNS cranial nerves | CN 3,7,9,10 |
activation of Vagus nerve | associated with the PNS "rest & digest" functions ex) slows heart rate |
SNS and Adrenal Medulla | releases NE 20% and EPI 80% |
PNMT | converts NE to EPI |
storage of EPI | stored in chromaffin granules until released |
PNS dominates in: | heart, bronchi, GI tract, bladder |
SNS dominates in: | adrenal medulla, blood vessels, skeletal muscles |
inhibition of one division leads to ____activity of the other division | increased activity |
blood vessel diameter is regulated solely by the ___ | SNS |
exceptions to vasoconstriction & vasodilation | "fight or flight" -BV in skeletal muscle dilate -BV in GI constrict to limit flow |
CNS regulation of ANS | reflex activity is highly regulated by the CNS -limbic lobe sends info to frontal lobe & hypothalamus |
reflex activity of ANS is mediated by: | the spinal cord and brain stem centers (medulla oblongata, pons, midbrain) |
medulla oblongata | contains the cardiac center & the vasomotor center -oversees GI activities |
pons | contains the respiratory center |
midbrain | contains oculomotor nerve |
Baroreceptors | stretch-sensitive nerve endings -maintains stable mean arterial pressure (MAP) |
Carotid baroreceptors | maintain blood flow to the brain |
Aortic arch baroreceptors | maintain peripheral BP |
Autoreceptors | presynaptic receptors that mediate the release of the SAME Neurotransmitter |
Heteroreceptors | presynaptic receptors that mediate the release of a DIFFERENT neurotransmitter |
Receptor regulations | -auto/hetero -receptors -desensitization -down/up regulation |
Receptor Desensitization | prolonged stimulation by agonist decreases ABILITY of receptor's response to stimulation -leads to drug tolerance |
Receptor downregulation | prolonged stimulation by agonist reduces NUMBER of receptors available for binding -leads to drug tolerance |
Receptor upregulation | long-term blockade of receptors increases the number of receptors ex) effect of an antagonist |
Biosynthesis of Ach at the Cholinergic Synapse (2) (PNS) | in the pre-synapse Choline + Acetyl-CoA combine by enzyme ChAT |
Biosynthesis of Ach at the Cholinergic Synapse (1) (PNS) | Choline is transported in the pre-synapse by Na+ dependent choline transporter (CHT) -transporter can be blocked by drug Hemicholinium |
Biosynthesis of Ach at the Cholinergic Synapse (3) (PNS) | Ach is transported from cytoplasm into vesicles by transporter VAT, along with peptides and ATP -transporter blocked by drug Vesamicol |
Release of Ach at the Cholinergic Synapse (4) (PNS) | Ca2+ channels activate via action potential and vesicles fuse to pre-synapse --> expulsion of Ach into synaptic cleft -process blocked by drug Botulinum toxin |
Metabolism of Ach at the Cholinergic Synapse (5) (PNS) | released Ach can act on: muscarinic GPCR or Nicotinic ionotropic receptors or endplate of skeletal muscle |
Metabolism of Ach at the Cholinergic Synapse (6) (PNS) | Ach is metabolized in the synapse by Acetylcholinesterase to acetate and choline |
Metabolism of Ach at the Cholinergic Synapse (7) (PNS) | Ach can also bind to autoreceptors and heteroreceptors on the pre-synapse, to control further release |
Catecholamines (SNS) | small molecule NTs -benzene with 2 ortho -OH & side chain amine |
principal catecholamines in the body: | NE, EPI, Dopamine |
Biosynthesis of NE & EPI: | Tyrosine>Dopa>Dopamine> (NE>EPI) (occurs only in adrenal medulla) |
Tyrosine hydroxylase | converts Tyrosine>Dopa |
Dopa decarboxylase | converts Dopa>Dopamine |
Dopamine b-hydroxylase | converts Dopamine>NE |
MAO & COMT enzymes | metabolize catecholamines to inactive metabolites (VMA & HVA) |
Biosynthesis of NE at the Noradrenergic synapse (1) (SNS) | Tyr is transported into nerve terminal by Na+ dependent carrier |
Biosynthesis of NE at the Noradrenergic synapse (2) (SNS) | Conversion in cytoplasm: Tyr>Dopa>Dopamine |
Biosynthesis of NE at the Noradrenergic synapse (3) (SNS) | transport of Dopamine from cytoplasm into vesicle by VMAT -VMAT blocked by the drug Reserpine |
Biosynthesis of NE at the Noradrenergic synapse (4) (SNS) | Conversion in the vesicle: Dopamine>NE |
Release of NE at the Noradrenergic synapse (5) (SNS) | action potential opens Ca2+ channel, & vesicles fuse with surface membrane --> expulsion of NE, peptides, ATP into cleft -process blocked by Guanethidine & Bretylium |
Release of NE at the Noradrenergic synapse (6) (SNS) | NE acts on GPCRs on postsynaptic neuron or neuroeffector organ (e.g. BVs) |
Release of NE at the Noradrenergic synapse (7) (SNS) | NE can also diffuse out of cleft --> metabolized by liver enzyme MAO |
Release of NE at the Noradrenergic synapse (8) (SNS) | NE can transport back into the nerve terminal by norepinephrine transporter (NET) -Cocaine and TCA drugs block NET |
Release of NE at the Noradrenergic synapse (9) (SNS) | NE can also bind to autoreceptors and heteroreceptors on the presynaptic nerve ending, to control further release |
Release of NE at the Noradrenergic synapse (10) (SNS) | NE can also be metabolized by enzyme COMT in the postsynaptic tissues |
Botulinum toxin | blocks release of Ach into the Cholinergic synapse |
Cocaine & Tricyclic Antidepressants (TCAs) | block norepinephrine transporter (NET) |
Guanethidine & Bretylium | blocks release of NE, peptides, ATP into the Noradrenergic synapse |
which synapse recycles the NTs? | Noradrenergic synapse |
which synapse doesn't recycle the NT? (is a waster) | Cholinergic synapse |
ANS effects on the eye | 1) pupil size 2) aqueous humor synthesis 3) far & near vision (accommodation) |
Mydriasis | SNS a1 receptor activation contracts radial (dilator) fibers of iris (pupil dilation) |
Miosis | PNS M3 receptor activation contract SPHINCTER (circular) fibers of iris (pupil shrinkage) |
effect of a2 receptors on ciliary body epithelium (aqueous humor) | decrease secretion of aqueous humor |
effect of b2 receptors on ciliary body epithelium (aqueous humor) | increase secretion of aqueous humor |
effect of b2 receptors on ciliary muscles (accommodation) | ciliary m. relax, suspensory ligaments pull against lens, lens become less convex (more flat) -for FAR vision |
effect of M3 receptors on ciliary muscles (accommodation) | ciliary m. contract, suspensory ligaments relax, lens become more convex (oval) |
accommodation of the eye effects the ___ | curvature of the lens (see near or far) |
Hemocholinium | inhibits --> Choline is transported in the pre-synapse by Na+ dependent choline transporter (CHT) |